Analyze Diet
Veterinary surgery : VS2000; 29(5); 420-429; doi: 10.1053/jvet.2000.7538

Fibrous tissue of subchondral cystic lesions in horses produce local mediators and neutral metalloproteinases and cause bone resorption in vitro.

Abstract: To define the release of nitric oxide (NO), prostaglandin E2 (PGE2), and the neutral metalloproteinases (NMPs) in horses with subchondral cystic lesions (SCL) and to study bone resorption triggered by conditioned media of fibrous tissue of SCL in vitro. Methods: Equine explant cultures of fibrous tissue of SCL, and synovial membrane and articular cartilage of normal horses and horses affected with moderate and severe osteoarthritis were performed. NO, PGE2, and NMP concentrations of media samples were measured, and osteoclast formation and activation was studied in vitro. Methods: Experiment 1: 32 horses with SCL (n = 8), normal joints (7), and joints with moderate (7) and severe (10) osteoarthritis (OA). Experiment 2: 22 horses with SCL (n = 3), normal joints (7), and chip fractures (12). Experiment 3: Conditioned media of fibrous tissue from 3 horses with SCL of the medial femoral condyle (n = 1), distal metacarpal bone (1), and tarsal bone (1). Methods: Determinations of local mediator concentrations were made with the Griess assay for NO and an enzyme immunoassay kit for PGE2 concentrations in biological fluids. Enzyme activities were assessed with radiolabeled substrates indicating collagenolytic, gelatinolytic, and caseinolytic activities. The resorption pit assay was used to assess osteoclast recruitment and activity. Results: Fibrous tissue of SCL produced NO, PGE2, and NMPs. Of all the variables measured, PGE2 concentrations were the highest in cystic tissue of SCL compared with synovial membrane and articular cartilage from normal joints and joints with chip fractures, indicating that this mediator may play an important role in pathological bone resorption associated with SCL. These findings were supported by the observation that conditioned media of SCL tissue were capable of recruiting osteoclasts and increasing their activity. Conclusions: Fibrous tissue of SCL released NO, PGE2, and NMPs into the culture media. It is suspected that intralesional fibrous tissue may play an active role in the pathological process of bone resorption occurring in SCL in horses and may be partly responsible for the maintenance, slow healing rate, and expansion of these lesions. Conclusions: Understanding the pathogenesis of SCL will help to establish successful therapy in horses affected with SCL.
Publication Date: 2000-09-22 PubMed ID: 10999456DOI: 10.1053/jvet.2000.7538Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study is about how fibrous tissue in subchondral cystic lesions (SCL) in horses creates substances that can lead to bone decay. The researchers also found that these tissues might play a role in the slow healing of these lesions.

Objective of the Research

  • The main objective of this research is to investigate the production of nitric oxide (NO), prostaglandin E2 (PGE2), and neutral metalloproteinases (NMPs) by subchondral cystic lesions in horses and to understand their role in bone resorption.

Methodology

  • Three experiments were conducted with a number of horses having SCL, normal joints, chip fractures, and joints with moderate to severe osteoarthritis.
  • Measurements of NO, PGE2, and NMP in media samples were taken, and the formation and activation of osteoclasts (cells that break down bone) in vitro (in a lab setting) were studied.
  • A method of detecting concentrations of local mediators, including the Griess assay for NO and an enzyme immunoassay kit for PGE2, was used.
  • Enzyme activity was determined by radio labeled substrates indicating collagenolytic, gelatinolytic, and caseinolytic activities.
  • The resorption pit assay was used to assess the recruitment and activity of osteoclasts.

Results

  • The study found that fibrous tissue in SCL in horses produces NO, PGE2, and NMPs.
  • PGE2 concentrations were found to be highest in cystic tissue of SCL as compared to synovial membrane and articular cartilage in normal joints and joints with chip fractures.
  • The research further observed that conditioned media of SCL tissue were capable of recruiting more osteoclasts and enhancing their activity.

Conclusions

  • The team concluded that the fibrous tissue of SCL released NO, PGE2, and NMPs, and could potentially play a role in the pathological bone resorption occurring in SCL in horses.
  • It was hence suspected that intralesional fibrous tissue might be responsible for maintaining, affecting the slow healing rate, and even expanding these lesions.
  • With this understanding of the pathogenesis (the manner of development) of SCL, the team believes it may help to devise a successful therapy for horses affected with SCL.

Cite This Article

APA
von Rechenberg B, Guenther H, McIlwraith CW, Leutenegger C, Frisbie DD, Akens MK, Auer JA. (2000). Fibrous tissue of subchondral cystic lesions in horses produce local mediators and neutral metalloproteinases and cause bone resorption in vitro. Vet Surg, 29(5), 420-429. https://doi.org/10.1053/jvet.2000.7538

Publication

ISSN: 0161-3499
NlmUniqueID: 8113214
Country: United States
Language: English
Volume: 29
Issue: 5
Pages: 420-429

Researcher Affiliations

von Rechenberg, B
  • Department of Veterinary Surgery, University of Zürich, Switzerland.
Guenther, H
    McIlwraith, C W
      Leutenegger, C
        Frisbie, D D
          Akens, M K
            Auer, J A

              MeSH Terms

              • Analysis of Variance
              • Animals
              • Bone Cysts / physiopathology
              • Bone Cysts / veterinary
              • Bone Resorption / enzymology
              • Bone Resorption / metabolism
              • Bone Resorption / veterinary
              • Cartilage, Articular / enzymology
              • Cartilage, Articular / metabolism
              • Culture Techniques
              • Dinoprostone / metabolism
              • Horse Diseases / enzymology
              • Horse Diseases / metabolism
              • Horse Diseases / physiopathology
              • Horses
              • Metalloendopeptidases / metabolism
              • Nitric Oxide / metabolism
              • Osteoarthritis / physiopathology
              • Osteoarthritis / veterinary
              • Synovial Membrane / enzymology
              • Synovial Membrane / metabolism

              Citations

              This article has been cited 9 times.
              1. Kaspiris A, Hadjimichael AC, Lianou I, Iliopoulos ID, Ntourantonis D, Melissaridou D, Savvidou OD, Papadimitriou E, Chronopoulos E. Subchondral Bone Cyst Development in Osteoarthritis: From Pathophysiology to Bone Microarchitecture Changes and Clinical Implementations. J Clin Med 2023 Jan 19;12(3).
                doi: 10.3390/jcm12030815pubmed: 36769464google scholar: lookup
              2. Gao L, Cucchiarini M, Madry H. Cyst formation in the subchondral bone following cartilage repair. Clin Transl Med 2020 Dec;10(8):e248.
                doi: 10.1002/ctm2.248pubmed: 33377663google scholar: lookup
              3. Li G, Chen L, Zheng Q, Ma Y, Zhang C, Zheng MH. Subchondral bone deterioration in femoral heads in patients with osteoarthritis secondary to hip dysplasia: A case-control study. J Orthop Translat 2020 Sep;24:190-197.
                doi: 10.1016/j.jot.2019.10.014pubmed: 33101970google scholar: lookup
              4. Golonka P, Kornicka-Garbowska K, Marycz K. SIRT1(+) Adipose Derived Mesenchymal Stromal Stem Cells (ASCs) Suspended in Alginate Hydrogel for the Treatment of Subchondral Bone Cyst in Medial Femoral Condyle in the Horse. Clinical Report. Stem Cell Rev Rep 2020 Dec;16(6):1328-1334.
                doi: 10.1007/s12015-020-10025-6pubmed: 32803696google scholar: lookup
              5. Hurtig MB, Buschmann MD, Fortier LA, Hoemann CD, Hunziker EB, Jurvelin JS, Mainil-Varlet P, McIlwraith CW, Sah RL, Whiteside RA. Preclinical Studies for Cartilage Repair: Recommendations from the International Cartilage Repair Society. Cartilage 2011 Apr;2(2):137-52.
                doi: 10.1177/1947603511401905pubmed: 26069576google scholar: lookup
              6. McErlain DD, Appleton CT, Litchfield RB, Pitelka V, Henry JL, Bernier SM, Beier F, Holdsworth DW. Study of subchondral bone adaptations in a rodent surgical model of OA using in vivo micro-computed tomography. Osteoarthritis Cartilage 2008 Apr;16(4):458-69.
                doi: 10.1016/j.joca.2007.08.006pubmed: 17900933google scholar: lookup
              7. Li X, Chen W, Liu D, Chen P, Wang S, Li F, Chen Q, Lv S, Li F, Chen C, Guo S, Yuan W, Li P, Hu Z. Pathological progression of osteoarthritis: a perspective on subchondral bone. Front Med 2024 Apr;18(2):237-257.
                doi: 10.1007/s11684-024-1061-ypubmed: 38619691google scholar: lookup
              8. Tönük ŞB, Yorgancıoğlu ZR, Ramadan SU, Kocaoğlu S. Relationship between DXA measured systemic bone mineral density and subchondral bone cysts in postmenopausal female patients with knee osteoarthritis: a cross-sectional study : Osteoarthritis cysts and bone mineral density. BMC Musculoskelet Disord 2024 Jan 11;25(1):50.
                doi: 10.1186/s12891-023-07141-ypubmed: 38212780google scholar: lookup
              9. Canonici F, Marcoccia D, Bonini P, Monteleone V, Innocenzi E, Zepparoni A, Altigeri A, Caciolo D, Tofani S, Ghisellini P, Rando C, Pechkova E, Rau JV, Eggenhöffner R, Scicluna MT, Barbaro K. Arthroscopic Treatment of a Subchondral Bone Cyst via Stem Cells Application: A Case Study in Equine Model and Outcomes. Biomedicines 2023 Dec 14;11(12).
                doi: 10.3390/biomedicines11123307pubmed: 38137527google scholar: lookup